Abstract. WIF-1 is a negative regulator of the Wnt-signaling pathway that may have important implications for tumorigenesis. Microarray analysis of whole genome expression in mesothelioma tissue revealed down-regulation of 491 genes and up-regulation of 167 genes involved mainly in Jak-STAT signaling (8 genes), MAPK signaling (16 genes) and Wnt signaling (13 genes) pathways. Of these, WIF-1 gene was down-regulated in mesothelioma 72-fold compared to normal tissue. We also analyzed WIF-1 and SFRPs promoter methylations in 46 mesothelioma tissues, 8 mesothelioma cell lines by methylation-specific polymerase chain reaction (MSP). WIF-1 promoter methylation was observed in 34 of 46 mesothelioma tissues (73.9%) and in all 8 mesothelioma cell lines. SFRP1, 2 and 4 promoter methylation was observed in 21 of 37 (56.8%), 26 of 42 (61.9%) and 17 of 36 (47.2%) mesothelioma tissues, respectively. Promoter methylation of any WIF-1 and/or SFRP genes was observed in 44 of 46 (95.6%) mesothelioma tissues. The treatment of mesothelioma cell lines with 5-aza-2'-deoxycytidine (5-aza-2dC) showed WIF-1 promoter methylation recovery followed by restoration of WIF-1 expression in 6 of 8 mesothelioma cell lines. The cytoplasmic expression of ß-catenin was observed in 38 of 43 cases of mesothelioma without any nuclear reactivity. The eight mesothelioma cell lines and 27 cases of mesothelioma examined showed no mutation in exon 3 of ß-catenin suggesting no alteration of canonical Wnt signaling pathway. Our data suggest that WIF-1 promoter methylation is a common event in mesothelioma.
Introduction
Mesothelioma derived from pleura or other mesothelial surfaces is an aggressive tumor with a poor prognosis (1) . Exposure to asbestos fibers is considered to be the main cause of mesothelioma, although the mechanism of tumorigenesis from mesothelial cells to mesothelioma is still unknown. Although mutations and deletions of p53 or RB tumor suppressor genes occur frequently in many cancers, those changes are extremely rare in mesothelioma (2, 3) . Cytogenetic analyses have shown frequent deletions of various chromosome loci in mesothelioma (4, 5) . The loss and/or inactivation of tumor suppressor genes, CDKN2A/ARF at 9p21 or NF2 at 22q12, are primarily reported in mesothelioma (1) . Recent studies on tumorigenesis have focused on epigenetic alterations including promoter methylation or histone deacetylation for playing roles in gene silencing without altering DNA sequence (6, 7) . RASSF1A, ESR1, IGFBP3, APC, CCND2, HPPBP1, BMP3b and BMP6 have been reported to be down-regulated by promoter methylation in mesothelioma. It has been suggested that these types of epigenetic changes contribute to tumorigenesis in mesothelioma (8) (9) (10) (11) .
Down-regulation of WIF-1 gene due to hypermethylation of its promoter has also been observed in other human cancers, including prostate, breast, lung, urinary bladder and gastrointestinal malignancies (12) (13) (14) . Furthermore, WIF-1 promoter methylation was found in 69.4% of malignant pleural effusions in NSCLC patients (13) , in 81.4% of early colorectal tumors (15) and in 92% of frozen mesothelioma tissue samples (16) . In the present study, we analyzed the whole gene expression of mesothelioma using genechip microarray and examined WIF-1 promoter methylation in mesothelioma tissue and in mesothelioma cell lines as well as the effects of a demethylating agent. Our aim was to ascertain the role of WIF-1 promoter methylation in tumorigenesis of mesothelioma.
Materials and methods
Gene expression analysis. Frozen tissues from four mesothelioma were crushed in liquid nitrogen and total RNA was isolated using the TRIzol reagent (Invitrogen Corp., Carlsbad, CA, USA), following by DNase treatment for 30 min at 37˚C (Turbo DNase, Ambion, TX, USA) and tested with RNA StdSens Analysis kit using Experion automated electrophoresis system (Bio-Rad Laboratories, CA, USA). Human genome focus array (Affymetrix Inc., CA, USA), containing 8500 gene probes was used to analyze gene expression profiles. cDNA was synthesized from 5 μg total RNA using the SuperScript II Reverse Transcriptase (Invitrogen Corp.) and purified using Genechip Sample Cleanup Module (Affymetrix Inc.) according to the manufacturer's instructions. Biotin-labeled cRNA was synthesized using the Genechip IVT Labeling kit (Affymetrix Inc.) and purified using Genechip Sample Cleanup Module (Affymetrix Inc.). Yield and size distribution of the labeled transcripts were determined with NanoVue spectrophotometer (GE Healthcare Bio-Sciences, Uppsala, Sweden) and Experion automated electrophoresis system (Bio-Rad Laboratories). After fragmentation using the fragmentation buffer from Genechip Sample Cleanup Module, cRNA were hybridized to the Human Genome Focus Array. Genechip were automatically stained with streptavidinphycoerythrin by using a fluidic station (Affymetrix Inc.) and scanned by Genechip Scanner 3000 (Affymetrix Inc.). The resulting images were processed by the accompanying software (Microarray Suite 5.0; Affymetrix Inc.). A global scaling approach was used to normalize signal intensities (TGT value = 500). The generated .CEL files after normalized data, with signal intensities >1.5, were analyzed with web-based GeneSifter analysis (Geospiza Inc., WA, USA). This program also produced gene ontology and z-score reports. The ontology were organized according to the principles of the Gene Ontology Consortium and included biological processes, molecular functions and cellular components. Statistical analysis of individual gene expression was performed with Student's t-test and corrected with Benjamini and Hochberg.
Formalin-fixed paraffin-embedded tissue samples. Forty-six mesothelioma tissue samples were obtained from the Department of Pathology at Hiroshima University. These samples included tissues from 38 male and 8 female patients with a mean age of 62.3 years, ranging from 26 to 83. The microscopic slides were reviewed in order to confirm the diagnosis, and they were reclassified using the current WHO histological classification (17) . Histologically, the samples comprised 24 epithelioid, 9 biphasic and 13 sarcomatoid mesotheliomas. Twenty-four non-neoplastic peripheral lung tissues containing visceral pleura (NPLVP) were also examined as a control in the study, 12 of the cases were obtained from lung cancer patients. The anonymized (unlinkable) tissue samples are provided by the Department of Pathology to investigators for molecular analyses. This is in accordance with the Ethics Guidelines For Human Genome/Gene Research enacted by the Japanese Government as tissue specimens are collected and used, based on the approval of the Ethics Review Committee of the Hiroshima University.
DNA extraction and methylation-specific PCR. Genomic DNA was extracted from mesothelioma tissues and cell lines using QIAamp DNA Mini kit (Qiagen, Hilden, Germany). Bisulfite modification of ~2 μg of genomic DNA was carried out with Epitect Bisulfite kit (Qiagen) according to the manufacturer's protocol. Universal methylated DNA (Chemicon International, Temecula, CA, USA) and unmethylated DNA were also included. Methylation-specific PCR was conducted on approximately 200 ng of bisulfite-modified DNA with methylation-specific and unmethylation-specific primers in 20 μl PCR volume using Epitect MSP kit (Qiagen) according to the manufacturer's protocol. The PCR products were resolved by electrophoresis on a 2% agarose gel. The gel was stained with ethidium bromide and photographed under UV Table I . Primer sequence and PCR conditions. 
transillumination. The primers and their annealing temperatures for the methylated and unmethylated sequences are summarized in Table I .
ß-catenin mutation analysis. The 10-μm tissue sections, after brief staining with hematoxylin were subjected to DNA extraction from tumor cell nests using sterilized curette. The DNA from dissected samples was extracted using QIAamp DNA Mini kit (Qiagen). For mutational analysis, the samples were subjected to PCR with two pair of primers (Table I) encompassing exon 3 of the ß-catenin gene, which contains the consensus GSK-3ß phosphorylation sites, using Primestar HS (Takara Bio, Tokyo, Japan). The electrophoresis of PCR products was done in a 2.5% (w/v) agarose gel, visualized under UV light with ethidium bromide staining, the specific PCR product was recovered using a QIAquick Gel Extraction kit (Qiagen). Isolated PCR products were sequenced on an Applied Biosystems 3130x Genetic Analyzer (Applied Biosystems Inc., Foster City, CA, USA) using BigDye Terminator v3.1 Cycle Sequencing kit (Applied Biosystems Inc.).
Mesothelioma cell lines and treatment with 5-aza-2-deoxycytidine (5-aza-2dC).
Eight mesothelioma cell lines, ACC-MESO1, ACC-MESO4 and HMMME purchased from the RIKEN BRC Cell Bank, Japan and MSTO-211H, NCI-H28, NCI-H226, NCI-H2052, NCI-H2452 purchased from American Type Culture Collection, Manassas, VA, USA. All cell lines were cultured in RPMI-1640 Glutamax media supplemented with 10% fetal bovine serum and 1% kanamycin, 1% fungizone at 37˚C in a humid incubator with 5% CO 2 (all purchased from Invitrogen Corp.). The cells were seeded at 10 5 cells in a 60-mm culture dish, allowed to attach for 24 h and then treated with 10 and 30 μM of 5-aza-2dC (Wako Pure Chemical Industries, Osaka, Japan) for 6 days. Culture media and 5-aza-2dC were changed every 48 h.
Real-time reverse transcription polymerase chain reaction (real-time RT-PCR).
Total RNA from 1x10 5 harvested cell lines treated with and without the demethylating agent was extracted, and amplification of WIF-1 mRNA was performed using the Power SYBR Green Cells-to-CT kit (Ambion, Austin, TX, USA) with Mx3000P real-time PCR system (Stratagene, Madison, WI, USA). RT-PCR primer sequences for WIF-1 and GAPDH are listed in Table I .
Western blot analysis. Total proteins from the mesothelioma cell line cultured with and without 5-aza-2dC treatments were prepared using cell lysis protein extraction reagent (CellLyEX1 kit, ToyoB-net, Tokyo, Japan). Equal amounts of proteins were subjected to electrophoresis on a 10% SDSpolyacrylamide ReadyGel J using Mini-protean tetra cell (Bio-Rad Laboratories). The proteins were transferred to Hybond-P PVDF membrane (GE Healthcare Life Sciences, Buckinghamshire, UK) using semi-dry blot (Bio-Rad Laboratories). Proteins were detected using the WesternDot Western blotting kit (Invitrogen Corp.) using Western Q (Scithrobe, Tokyo, Japan). The primary polyclonal antibodies were anti-WIF-1 (1:1000; Cell Signaling Technologies, Danvers, MA, USA) and ß-actin (N21, 1:1000; Santa Cruz Biotechnology, CA, USA) as a normalizing reference. Table II . Highly altered gene expression in mesothelioma. 
Statistical analysis of log tranformed data by t-test with Benjamini and Hochberg correction.
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a Statistical analysis of log tranformed data by t-test with Benjamini and Hochberg correction.
in <5% of the tumor cells was considered negative and scored as 0. Immunoreactivity in 5-50% of the tumor cells was scored as 1+ and immunoreactivity in >50% of the tumor cells was scored as 2+. Cases were considered positive when >5% of the tumor cells showed WIF-1 expression.
Results
Gene expression analysis of malignant mesothelioma. Analysis of whole genome microarray expression in mesothelioma revealed down-regulation of 491genes and up-regulation of 167 genes with highly expressed genes as mentioned in of NPLVP, respectively. The frequencies of SFRP promoter methylation were higher in mesothelioma than in nonneoplastic pleural tissue, although the differences were not statistically significant. The number of cases with methylation of the promoter for any one of WIF-1 or SFRP1, 2 and 4 was significantly higher in mesothelioma tissues (44 of 46, 95.6%) than in NPLVP (12 of 24, 50%) (P<0.01) (Table IV) . Electropherograms showing WIF-1 and SFRP promoter methylation of representative cases are shown in Fig. 1 .
WIF-1 and SFRP promoter methylation in mesothelioma cell lines.
Methylation-specific PCR revealed WIF-1 promoter methylation in the 8 mesothelioma cell lines ( Fig. 2A ) (Table IV) . Promoter methylation of SFRP1, 2 and 4 genes were also found in 7, 7 and 3 of 8 mesothelioma cell lines, respectively (Fig. 2B) .
WIF-1 promoter methylation status and WIF-1 expression
after 5-aza-2dC treatment. WIF-1 mRNA was detected in 6 of 8 mesothelioma cell lines (ACC-MESO1, ACC-MESO4, Table IV . Frequency of promoter methylation of WIF-1 and SFRPs in mesothelioma and NPLVP. -
Positive methylation in NPLVP was observed in the normal tissue obtained from lung cancer patients.
- HMMME, MSTO-211H, NCI-H28, NCI-H226) after 5-aza2dC treatment (Fig. 3A) . Western blot analysis (Fig. 3B) showed increased expression of WIF-1 protein in all of these 6 mosothelioma cell lines after 5-aza-2dC treatment.
WIF-1 expression in mesothelioma tissue and cell lines.
Eight of 37 cases (21.6%) of mesothelioma showed cytoplasmic staining of WIF-1 in tumor cells (Fig. 4) (Table IV) . Furthermore, 3 of 28 (10.7%) mesothelioma cases with WIF-1 promoter methylation and 5 of 9 (55.6%) mesothelioma cases without WIF-1 promoter methylation showed WIF-1 expression. WIF-1 promoter methylation was statistically correlated to WIF-1 expression (P=0.011). In addition, all 20 cases of non- Fig. 5B) , however, the restoration of WIF-1 expression was observed in all of these 6 mesothelioma cell lines after 5-aza-2dC treatment (Fig. 5C ). Two other cell lines showed no expression of WIF-1 mRNA or protein regardless of 5-aza-2dC treatment.
ß-catenin expression and mutation. ß-catenin nuclear immunoexpression was not observed in any of 43 cases. However, the cytoplasmic expression, crowded near to nucleus, was found 38 cases, 17 cases showing cytoplasmic expression in <10% of the tumor cells (immunoscore 1) and 21 cases showing cytoplasmic expression in >10% of the tumor cells (immunoscore 2). The 8 mesothelioma cell lines also showed cytoplasmic expression in >10% of the tumor cells (immunoscore 2). Mutation analysis of 27 cases of mesothelioma tissue and 8 mesothelioma cell lines did not show any mutation in GSK-3ß phosphorylation sites of exon 3 of ß-catenin gene (Table V) .
Discussion
In the present study, microarray analysis of whole genome expression in mesothelioma revealed down-regulation of 491 genes and up-regulation of 167 genes. Thirteen genes were involved with Wnt signaling pathways. Wnt-signaling pathway has been shown to play a critical role in human carcinogenesis. Overexpression of Wnt has been reported in many cancer types and suggested to play an important role in Wnt signaling in both lung cancer and mesothelioma (18, 19) . The role of WIF-1, a wnt inhibitory protein, in carcinogenesis is becoming more clearly understood. We found WIF-1 expression was down-regulated in mesothelioma 72-fold compared to normal tissue. We tried to explain the downregulation of WIF-1 gene by MSP analysis of the promoter methylation of WIF-1. We also analyzed the promoter methylation of SFRP1, 2, 4 (secreted frizzled-related protein) genes, other Wnt inhibitory proteins, although microarray analysis did not show alteration of SFRP expression. Both of these genes inhibit activation of the Wnt-signaling pathway by preventing the binding of Wnt ligands to the frizzled transmembrane receptors. The frequency of WIF-1 methylation in mesothelioma tissues was similar to that reported in previous studies (13, 15, 29) and its frequency is higher in mesothelioma compared to that of other genes, such as p16 (11.4%), RASSF1A (20.2%) and IGFBP-3 (32%) (8, 9, 20) . This result suggests that WIF-1 methylation might play an important role in mesothelioma. The three different Wnt-signaling pathways, Wnt-ß-catenin (canonical), planar cell polarity and Wnt-Ca 2+ pathways (non-canonical) are known; canonical pathway being studied in details. We analyzed the expression of ß-catenin in mesothelioma tissue and cell lines. We found the cytoplasmic expression of ß-catenin in most of the tumor cells without its accumulation in nucleus. In addition, we could not detect any mutation in GSK-3ß phosphorylation sites of exon 3 of ß-catenin gene, suggesting that mesothelioma did not involve the canonical pathway. Microarray analysis of this study did not reveal ß-catenin alteration. Instead, we found alteration of PLC and CaMKII, genes involved in Wnt-Ca 2+ pathway. Therefore, it may be presumed that Wnt-signaling pathway alteration in mesothelioma is not the canonical pathway, but the possibility of alteration in Wnt-Ca 2+ pathway. Further detailed study is needed to confirm such hypothesis.
Treatment with 5-aza-2dC has been reported to result in re-expression of WIF-1 in bladder cancer cell lines (21) and gastrointestinal cancer cell lines (14) . In the present study, we treated 6 mesothelioma cell lines with the demethylating agent 5-aza-2dC and observed re-expression of WIF-1 mRNA and WIF-1 protein. We also found that WIF-1 protein expression was down-regulated in 82.1% of the methylated mesothelioma tissues examined. These results suggest that the WIF-1 gene is down-regulated by methylation of its promoter in
